Feasibility of next-generation sequencing (NGS) for squamous non-small cell lung cancer (NSCLC): Implications for the NCI LungMAP study.

被引：0
|
作者：
Sacher, Adrian G.
Sholl, Lynette M.
Mach, Stacy L.
Johnson, Bruce E.
Hammerman, Peter S.
Janne, Pasi A.
Oxnard, Geoffrey R.
机构：
[1] Dana Farber Canc Inst, Cambridge, MA USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Newton Ctr, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8096
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Effectiveness of nationwide insurance coverage for next-generation sequencing in advanced non-small cell lung cancer: A real-world data study.
    Kang, Dong-Won
    Park, Sun-Kyeong
    Yu, Ye Lee
    Lee, Dae Ho
    Kang, Sokbom
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis
    Tan, Aaron C.
    Lai, Gillianne G. Y.
    Tan, Gek San
    Poon, Shou Yu
    Doble, Brett
    Lim, Tse Hui
    Aung, Zaw Win
    Takano, Angela
    Tan, Wan Ling
    Ang, Mei-Kim
    Tan, Bien Soo
    Devanand, Anantham
    Too, Chow Wei
    Gogna, Apoorva
    Ong, Boon-Hean
    Koh, Tina P. T.
    Kanesvaran, Ravindran
    Ng, Quan Sing
    Jain, Amit
    Rajasekaran, Tanujaa
    Lim, Alvin S. T.
    Lim, Wan Teck
    Toh, Chee Keong
    Tan, Eng-Huat
    Lim, Tony Kiat Hon
    Tan, Daniel S. W.
    LUNG CANCER, 2020, 139 : 207 - 215
  • [43] A single center experience with next generation sequencing (NGS) for the care of advanced non-small-cell lung cancer (NSCLC).
    Rangachari, Deepa
    VanderLaan, Paul A.
    Le, Xiuning
    Folch, Erik
    Kent, Michael S.
    Gangadharan, Sidharta P.
    Majid, Adnan
    Haspel, Richard L.
    Joseph, Loren
    Huberman, Mark
    Costa, Daniel Botelho
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] VALUE OF DRIVER MUTATION TESTING STRATEGIES BASED ON NEXT-GENERATION SEQUENCING (NGS) FOR PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (MNSCLC)
    Liu, S.
    Shenolikar, R.
    Herrera-Restrepo, O.
    Anaya, P.
    Yu, H.
    VALUE IN HEALTH, 2021, 24 : S27 - S27
  • [45] Molecular profiling of non-small cell lung cancer (NSCLC) in Asia with targeted next-generation sequencing (NGS): Interim analysis of a co-operative group study (ATORG-001)
    Tan, A. C.
    Loong, H.
    Ho, G. F.
    Seet, A.
    Chiam, B.
    Cheah, D. Q.
    Tan, G. S.
    Lim, K. H.
    Yang, J. C-H.
    Mok, T. S. K.
    Kim, D-W.
    Tan, D. S. W.
    ANNALS OF ONCOLOGY, 2019, 30
  • [46] Simultaneous Detection of Gene Rearrangements and Variants in Non-Small Cell Lung Cancer by Next-Generation Sequencing
    Xu, Shuo
    Boag, Alexander
    Mates, Mihaela
    Chen, Lina
    Feilotter, Harriet
    MODERN PATHOLOGY, 2016, 29 : 487A - 487A
  • [47] Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non-Small Cell Lung Cancer
    Yu, Tiffany M.
    Morrison, Carl
    Gold, Edward J.
    Tradonsky, Alison
    Arnold, Renee J. G.
    VALUE IN HEALTH, 2018, 21 (11) : 1278 - 1285
  • [48] Routine Clinical Mutation Profiling of Non-Small Cell Lung Cancer Using Next-Generation Sequencing
    Deeb, Kristin K.
    Hohman, Colleen M.
    Risch, Nicholas F.
    Metzger, Daniel J.
    Starostik, Petr
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (07) : 913 - 921
  • [49] Concordance of Next-Generation Sequencing Between Tissue and Liquid Biopsies in Non-Small Cell Lung Cancer
    Basher, F.
    Saravia, D.
    Lopes, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S447 - S447
  • [50] Identification of Clinically Significant MUTYH Deletion by Next-Generation Sequencing in Non-Small Cell Lung Cancer
    Fong, A. H. W.
    Lau, E. Y. T.
    Cheung, W. K. C.
    Cho, W. C. S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (03): : S53 - S53
12345